3-CPM: Extremely limited human pharmacology and toxicology data exist. A 2014 patent describes its activity as a selective dopamine releasing agent. Reported as more serotonergic than 3-FPM but still primarily dopaminergic. Community reports describe increased caustic damage to mucous membranes comp
Related pages